Editorial Picks
Hand-picked stories offering depth, insight, and perspective on global cannabis developments.
Editorial Picks · page 5
- UK & Europe
Germany’s Drug Commissioner Backs Cannabis Pilot Projects in Break With CDU Party Line
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the country’s booming cannabis industry has been bracing for a crackdown.
- Medical Cannabis
Vertanical Secures Milestone FDA Breakthrough Designation for Cannabis Pain Drug Ahead of Imminent European Launch
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in prime position to become the first FDA-approved cannabis-derived medicine for pain, and only the second such approval since Epidiolex in 2018.
- Industry Trends
Cannabis Europa London 2026: Key Insights, Day 2
Live Cannabis Europa 2026 London, UK From Plant to Patient: Why Genetics Must Lead Medical Cannabis Outcomes Arjan Roskam, Green House Genetics; Dave Auger, Big League Genetics; Adele Hollman, Sanity Group; moderated by Alex Fraser, Grow Group Telemedicine in Germany: Maturity, Regulation and What Comes Next Kristine Lütke, 365 Sherpas GmbH; Dirk Heitepriem, German Cannabis…
- Events
Business of Cannabis Awards 2026: Our Esteemed Winners
As the sun finally dipped over London on the hottest day of the year, the buzz that had filled the Barbican throughout the first day of Cannabis Europa London 2026 moved a few streets east to 83 Rivington, as the tone shifted from debate to celebration.
- Industry Trends
Cannabis Europa London 2026 – Key Insights, Day 1
Live Cannabis Europa 2026 London, UK Cannabis Europa London is back at The Barbican Centre for two days of conversations with global cannabis leaders, policymakers, industry analysts and patient representatives, and, as ever, the sun has shown up.
- Supply Chain
UK Medical Cannabis Imports Hit 30 Tonnes as Canadian Producers Bypass European Processors
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis.
- Events
Business of Cannabis Awards 2026: Shortlist Announced
The shortlist for the third annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, has been announced today.
- CBD Market
Greece Moves to Ban Hemp Flower Sales, Despite Government Advisory Body Warning of ‘Conflict’ With EU Law
Last week (April 27), the deadline for Greek industry stakeholders to have their say on a controversial new hemp ban expired.
- US & Canada
‘Not Immediately Compliant’: What the CRS Says America’s Rescheduling Order Actually Delivers
Since President Trump issued an executive order to expedite cannabis rescheduling in December 2025, questions over the legal implications of this route have hung over the industry.
- CBD Market
America’s CBD Industry Now Faces Same Evidential Battle Europe Has Been Fighting for 8 Years
The long and arduous journey to regulate cannabidiol (CBD) in Europe, which began in 2018 with the European Union’s classification of CBD as a ‘novel food’, is now playing out in the courtrooms of the United States.
- CBD Market
The War on Europe’s Legal Hemp Industry
In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic, regardless of THC content, following multiple failed attempts to decimate the industry.
- Industry Trends
DEA’s Schedule III Cannabis Order: A Free-For-All for Telehealth Platforms, or the Perfect Setup for the Entire Industry?
As the industry’s (more than justified) excitement over last week’s rescheduling announcement begins to subside, the regulatory reality is settling in.
